Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Cancer Research

• Publication date

  1988-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3130182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin.

  1988cited by this paper
• Increase in radioresponse of murine tumors by treatment with indomethacin.

  1988cited by this paper
• Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability.

  1987cited by this paper
• Interactions of natural effector cells and prostaglandins in the control of metastasis.

  1987cited by this paper
• Production of platelet thromboxane A2 inactivates purified human platelet thromboxane synthase.

  1986cited by this paper
• Stimulation of endothelial cell prostacyclin formation by interleukin-2.

  1986cited by this paper
• Effect of the radiosensitizer misonidazole and the radioprotector diethyldithiocarbamate on spontaneous metastasis formation of murine tumors.

  1986cited by this paper
• Immune regulation of the L5178Y murine tumor-dormant state. I. In vivo and in vitro effects of prostaglandin E2 and indomethacin on tumor cell growth

  1986cited by this paper
• Failure of indomethacin to inhibit growth of the R3230AC mammary tumor in rats.

  1985cited by this paper
• Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.

  1984cited by this paper
• Prostaglandin concentrations and prostaglandin synthetase activity in N-nitrosomethylurea-induced rat mammary adenocarcinoma.

  1983cited by this paper
• Prostaglandins and cancer

  1982cited by this paper
• Platelet-derived growth factor and thromboxane are necessary for liver regeneration.

  1981cited by this paper
• Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor.

  1981cited by this paper
• Prostaglandins and cancer: a review of tumor initiation through tumor metastasis.

  1981cited by this paper
• Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.

  1981cited by this paper
• Prostaglandin modulation of development of cell-mediated immunity in culture

  1980cited by this paper
• Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin

  1980cited by this paper
• Inhibition of murine natural killer cell activity by prostaglandins.

  1980cited by this paper
• Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids.

  1980cited by this paper
• Production of prostaglandin E2 by tumor cells in vitro.

  1980cited by this paper
• The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells.

  1980cited by this paper
• Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

  1980cited by this paper
• Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound.

  1979cited by this paper
• Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential.

  1979cited by this paper
• Endogenous prostaglandin E2 synthesis inhibits growth of polyoma virus-transformed 3T3 fibroblasts.

  1979cited by this paper
• Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.

  1978cited by this paper
• Mechanism of inhibition of tumour growth by aspirin and indomethacin.

  1978cited by this paper
• Automatic processing and interpretation of DNA distributions: comparison of several techniques.

  1978cited by this paper
• In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.

  1977cited by this paper
• Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse.

  1976cited by this paper
• Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.

  1975cited by this paper
• Subversion of immune system by tumor cells and role of prostaglandins.

  1975cited by this paper
• Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.

  1974cited by this paper
• The relationship between concentration of prostaglandin E and rates of cell replication.

  1974cited by this paper
• The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast Cancer

  1973cited by this paper
• Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds.

  1972cited by this paper

• Effects of Aerobic Treadmill Training on Oxidative Stress Parameters, Metabolic Enzymes, and Histomorphometric Changes in Colon of Rats with Experimentally Induced Hyperhomocysteinemia

  2024cites this paper
• Effects of different environmental intervention durations on the intestinal mucosal barrier and the brain-gut axis in rats with colorectal cancer

  2022cites this paper
• Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity

  2015cites this paper
• Cyclo-Oxygenase-2 and its Inhibition in Cancer

  2012cites this paper
• Roles of Hormones and Signaling Molecules in Describing the Relationship Between Obesity and Colon cancer

  2011cites this paper
• Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.

  2011cites this paper
• Physical Activity Before and After Diagnosis of Colorectal Cancer

  2010cites this paper
• Expression of cyclooxygenase-2 (COX-2) in an advanced metastasized hypopharyngeal carcinoma and cultured tumor cells

  2010cites this paper
• The Cyclooxygenase-2 Inhibitor Nimesulide, a Nonsteroidal Analgesic, Decreases the Effect of Radiation Therapy in Head-and-Neck Cancer Cells

  2009cites this paper
• Alteration of gene expression in rat colon mucosa after exercise.

  2008cites this paper
• Exercise Associated Genes and Their Involvement in the Prevention of Colon Cancer : A Voluntary Running Experiment in a Rat Model

  2008cites this paper
• Exercise reduces inflammation and cell proliferation in rat colon carcinogenesis.

  2008cites this paper
• Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.

  2008cites this paper
• The A / J Mouse Lung as a Model for Developing New Chemointervention Strategies

  2007cites this paper
• Alkylating agents and cancer therapy

  2007cites this paper
• Physical Activity Before and After Diagnosis of Colorectal Cancer

  2007cites this paper
• Physical activity before and after diagnosis of colorectal cancer: disease risk, clinical outcomes, response pathways and biomarkers.

  2007cites this paper
• Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.

  2007cites this paper
• Effects of Indomcthacin, Cytokines, and Cyclosporin A on Tumor Growth and the Subsequent Development of Cancer Cachexia1

  2006cites this paper
• Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours—an experimental study in rats

  2005cites this paper
• Mechanisms Associating Physical Activity with Cancer Incidence: Exercise and Prostaglandins

  2005cites this paper
• Radiotherapy and Chemotherapy

  2005cites this paper
• Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy.

  2005cites this paper
• Cyclo-Oxygenase-2 Enzyme and Its Inhibition in Tumor Growth and Therapy

  2005cites this paper
• Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.

  2004cites this paper
• Synergy between Celecoxib and Radiotherapy Results from Inhibition of Cyclooxygenase-2-Derived Prostaglandin E2, a Survival Factor for Tumor and Associated Vasculature

  2004cites this paper
• Accelerated genetic destabilization and dormancy: two distinct causes of resistance in metastatic cells; 10585ical magnitude, therapeutic approaches

  2004cites this paper
• Molecular targeting in radiotherapy of lung cancer.

  2004cites this paper
• Cyclooxygenase in the treatment of glioma: its complex role in signal transduction.

  2004cites this paper
• COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer

  2004cites this paper
• Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.

  2004cites this paper
• Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies

  2004cites this paper
• Apoptosis in P388 Leukemia Cells Induced by Specific Inhibitors of 5- and 12-Lipoxygenase and the Product of Cyclooxygenase, Prostaglandin E2

  2004cites this paper
• In Vitro Proliferation of Fibrosarcoma Cells Depends on Intact Functions of Lipoxygenases and Cytochrome P-450-Monooxygenase

  2004cites this paper
• COX-2 inhibition as a tool to treat and prevent colorectal cancer.

  2004cites this paper
• Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer.

  2004cites this paper
• Physical inactivity, energy intake, obesity and the risk of rectal cancer in Canada

  2003cites this paper
• Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.

  2003cites this paper
• Potential for Inhibitors of Cyclooxygenase-2 to Enhance Tumor Radioresponse

  2003cites this paper
• Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents.

  2003cites this paper
• Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?

  2003cites this paper
• Combined-Modalit y T reatment o f S olid T umors U sing Radiotherapy a nd M olecular T argeted A gents

  2003cites this paper
• COX-2 Inhibitors as Radiosensitizing Agents for Cancer Therapy

  2003cites this paper
• Role of Cyclooxygenase-2 (COX-2) and Its Inhibition in Tumor Biology and Radiotherapy

  2003cites this paper
• The effect of betel nut extract on cell growth and prostaglandin endoperoxide synthase in human epidermoid carcinoma cells.

  2002cites this paper
• Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies.

  2002cites this paper
• The Effect of Nonsteroidal Anti-inflammatory Drugs Ibuprofen, Flurbiprofen, and Diclofenac on In Vitro and In Vivo Growth of Mouse Fibrosarcoma

  2002cites this paper
• Pronounced radiosensitization of cultured human cancer cells by COX inhibitor under acidic microenvironment.

  2002cites this paper
• Indomethacin lowers the threshold thermal exposure for hyperthermic radiosensitization and heat-shock inhibition of ionizing radiation-induced activation of NF-κB

  2002cites this paper
• Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines.

  2002cites this paper
• Prostaglandin E2 concentrations in naturally occurring canine cancer.

  2001cites this paper
• A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

  2001cites this paper
• Synergistic effect of indomethacin with adriamycin and cisplatin on tumor growth.

  2001cites this paper
• Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse.

  2001cites this paper
• Locoregional immunotherapy in cancer patients: Review of clinical studies

  2000cites this paper
• Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.

  2000cites this paper
• Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.

  2000cites this paper
• Locoregional immunotherapy in cancer patients: review of clinical studies.

  2000cites this paper
• Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa.

  1999cites this paper
• Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme

  1999cites this paper
• Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.

  1999cites this paper
• Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.

  1998cites this paper
• Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study

  1998cites this paper
• Synergistic Effects of 13-cis Retinoic Acid and Arachidonic Acid Cascade Inhibitors on Growth of Head and Neck Squamous Cell Carcinoma in Vitro

  1998cites this paper
• The influence of zymosan and indomethacin on liver and kidney tumor growth. An experimental study in rats.

  1997cites this paper
• Cancer immunotherapy: potential involvement of mediators

  1997cites this paper
• Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats.

  1997cites this paper
• Tumor cell-endothelial cell interactions: evidence for roles for lipoxygenase products of arachidonic acid in metastasis.

  1997cites this paper
• Tumor suppressive action of indomethacin is NK-cell-independent.

  1997cites this paper
• Prostaglandins, their inhibitors and cancer.

  1996cites this paper
• Signal transduction inhibitors as modifiers of radiation therapy in human prostate carcinoma xenografts

  1996cites this paper
• Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.

  1996cites this paper
• Dietary linoleic acid-stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor.

  1996cites this paper
• Chemoprevention by dehydroepiandrosterone and indomethacin in a rat multiorgan carcinogenesis model.

  1995cites this paper
• Eicosanoids and radiation.

  1995cites this paper
• Effects related to indomethacin prolonged survival and decreased tumor-growth in a mouse-tumor model with cytokine dependent cancer cachexia.

  1995cites this paper
• The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury.

  1995cites this paper
• Cancer escape from immune surveillance: how can it be overcome by gene transfer?

  1994cites this paper
• Opposing Effects of Indomethacin and Nordihydroguaiaretic Acid on Macrophage Function and Tumor Growth

  1994cites this paper
• [Omega-3 unsaturated fatty acids: therapeutic applications].

  1994cites this paper
• Application of chemical immunomodulators to the treatment of cancer and AIDS.

  1994cites this paper
• Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells.

  1994cites this paper
• Comparison of prostanoids and their precursor fatty acids in human hepatocellular carcinoma and noncancerous reference tissues.

  1993cites this paper
• Platelet activation by cells isolated from human tumor tissues: effect of cyclooxygenase blockade.

  1993cites this paper
• The effect of interleukin 1 alpha on acetaminophen-induced hepatotoxicity.

  1993cites this paper
• Cyclooxygenase inhibitors - invitro and invivo effects on antitumor alkylating-agents in the emt-6 murine mammary-carcinoma.

  1993cites this paper
• The A/J mouse lung as a model for developing new chemointervention strategies.

  1993cites this paper
• Involvement of inflammatory mediators in macrophage antitumor activity

  1993cites this paper
• Inhibitory Effects of Inhibitors of Arachidonic Acid Metabolism on the Evolution of Rat Liver Preneoplastic Foci into Nodules and Hepatocellular Carcinomas with or without Phenobarbital Exposure

  1993cites this paper
• Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

  1993cites this paper
• The effect of interleukin 1α on acetaminophen-induced hepatotoxicity

  1993cites this paper
• Potentiation of Tumor Radioresponse by Combination of Indomethacin with the Hypoxic Cell Radiosensitizer Misonidazole

  1993cites this paper
• Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.

  1993cites this paper
• Changes in the populations of null, NK1.1+, and Thy1lo lymphocytes in the bone marrow of tumor-bearing mice: effect of indomethacin treatment.

  1992cites this paper
• Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin.

  1992cites this paper
• Human melanoma‐mediated inhibition of autologous CD4+ helper tumor‐infiltrating lymphocyte growth in vitro

  1992cites this paper
• Effect of the chemopreventive agents piroxicam and D,L-alpha-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis.

  1992cites this paper
• Leukotriene C4-induced radioprotection: the role of hypoxia.

  1992cites this paper
• Effect of irradiation on the prostaglandin system of human hypernephroma cells.

  1992cites this paper
• Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.

  1992cites this paper